Hetero Labs gets CDSCO Panel nod to study Tegoprazan tablet 50 mg Dr. Divya Colin13 May 2025 5:45 PM ISTNew Delhi: Responding to the proposal presented by Hetero Labs, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Tegoprazan Shows Superior Efficacy and Safety in Treating Esophageal Conditions in Phase 3 trial Dr. Kamal Kant Kohli9 May 2025 8:45 PM ISTIn a phase 3 trial Tegoprazan Shows Superior Efficacy and Safety in Treating Esophageal Conditions. It was found that Tegoprazan acted faster and was...
Potassium-Competitive Acid Blockers: AGA Review Offers Insights on Optimal Use in GI Disorders Medha Baranwal27 Jan 2025 8:30 PM ISTUSA: The American Gastroenterological Association (AGA) has released a Clinical Practice Update (CPU) aimed at integrating potassium-competitive acid...
Dr Reddys Laboratories gets CDSCO Panel Nod to import, market Tegoprazan for gastrointestinal diseases Susmita Roy28 Nov 2024 6:00 PM ISTNew Delhi: In a significant development, the pharmaceutical major Dr Reddys Laboratories has got the go-ahead from the Subject Expert Committee (SEC)...
Dr. Reddy's Gets CDSCO Panel Nod To Study Tegoprazan for gastrointestinal diseases Dr. Divya Colin4 July 2023 6:00 PM ISTNew Delhi: The drug major Dr. Reddy's Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Revise Phase III CT protocol: CDSCO Panel Tells Dr Reddy's over Tegoprazan Dr. Divya Colin15 April 2023 6:00 PM ISTNew Delhi: In response to the proposal to conduct a Phase III clinical trial presented by the drug major Reddy's Laboratories, the Subject Expert...
Dr Reddys Labs, HK inno.N Corporation ink pact to commercialize Tegoprazan in India, 6 key emerging Markets Ruchika Sharma12 May 2022 12:19 PM ISTThe agreement grants Dr. Reddy's the exclusive rights to develop and commercialise Tegoprazan under its own trademark in these markets for 10 years...
